Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients

Renal Failure

Volumn 24, Issue 2, 2002, Pages 175-186

  Nakamura, Satoko ^a   Sasaki, Osamu ^a   Nakahama, Hajime ^a   Inenaga, Takashi ^a   Kimura, Genjiro ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Dialysis; Hypertension; Left ventricular hypertrophy; Mortality

Indexed keywords

ADULT; ARTICLE; CARDIOMEGALY; CHRONIC KIDNEY FAILURE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; THORAX RADIOGRAPHY; CARDIOVASCULAR DISEASE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RENAL REPLACEMENT THERAPY; RISK; TIME;

CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TIME FACTORS; HUMANS; MIDDLE AGED;

EID: 0035987787     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120004094     Document Type: Article

References (33)

1. An overview of dialysis treatment in Japan (as of Dec 31, 1996)
2. Cardiac function and hematocrit level
3. Left ventricular dysfunction in dialysis subjects
4. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the framingham study
5. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
6. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study
7. Role of systolic blood pressure in determining prognosis of hemodialyzed patients
8. Interaction between hypertension and other cardiovascular risk factors in survival of hemodialyzed patients
9. Framingham study insights into hypertensive risk of cardiovascular disease
10. Left ventricular hypertrophy: Relationship of anatomic, echocardiographic and electrocardiographic findings
11. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
12. Correlation between chest film and angiographic assessment of left ventricular size
13. Cardiac disease in chronic uremia: Clinical outcome and risk factors
14. Clinical and echocardiographic cardiovascular disease in end stage renal disease: Prevalence, associations and prognosis
15. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients
16. Impact of left ventricular hypertrophy on survival in end-stage renal disease
17. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease
18. The clinical course of left ventricular hypertrophy in dialysis patients
19. The prognostic importance of left ventricular geometry in uremic cardiomyopathy
20. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
21. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients
22. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
23. Primary hyperparathyroidism; incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy
24. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy
25. Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients
26. Structural causes of cardiac dysfunction in uremia
27. In vitro approach to uremic cardiomyopathy
28. Hypertension
29. Hypertension in dialysis subjects
30. Regression of left ventricular hypertrophy in hypertensive dialyzed patients on long-term antihypertensive therapy
31. Influence of long-term amelioration of anemia and blood pressure on left ventricular hypertrophy in hemodialyzed patients
32. Follow-up of changes induced by anemia compensation in normotensive hemodialysis patients with left ventricular hypertrophy